Talk to us?

Oral and Maxillofacial Surgery - NEETMDS- courses
Oral and Maxillofacial Surgery

Local Anesthetic (LA) Toxicity and Dosing Guidelines

Local anesthetics (LAs) are widely used in various medical and dental procedures to provide pain relief. However, it is essential to understand their effects on the cardiovascular system, potential toxicity, and appropriate dosing guidelines to ensure patient safety.

Sensitivity of the Cardiovascular System

  • The cardiovascular system is generally less sensitive to local anesthetics compared to the central nervous system (CNS). However, toxicity can still lead to significant cardiovascular effects.

Effects of Local Anesthetic Toxicity

  1. Mild Toxicity (5-10 μg/ml):

    • Myocardial Depression: Decreased contractility of the heart muscle.
    • Decreased Cardiac Output: Reduced efficiency of the heart in pumping blood.
    • Peripheral Vasodilation: Widening of blood vessels, leading to decreased blood pressure.
  2. Severe Toxicity (Above 10 μg/ml):

    • Intensification of Effects: The cardiovascular effects become more pronounced, including:
      • Massive Vasodilation: Significant drop in blood pressure.
      • Reduction in Myocardial Contractility: Further decrease in the heart's ability to contract effectively.
      • Severe Bradycardia: Abnormally slow heart rate.
      • Possible Cardiac Arrest: Life-threatening condition requiring immediate intervention.

Dosing Guidelines for Local Anesthetics

  1. With Vasoconstrictor:

    • Maximum Recommended Dose:
      • 7 mg/kg body weight
      • Should not exceed 500 mg total.
  2. Without Vasoconstrictor:

    • Maximum Recommended Dose:
      • 4 mg/kg body weight
      • Should not exceed 300 mg total.

Special Considerations for Dosing

  • The maximum calculated drug dose should always be decreased in certain populations to minimize the risk of toxicity:
    • Medically Compromised Patients: Individuals with underlying health conditions that may affect drug metabolism or cardiovascular function.
    • Debilitated Patients: Those who are physically weakened or have reduced physiological reserve.
    • Elderly Persons: Older adults may have altered pharmacokinetics and increased sensitivity to medications.

Vestibuloplasty

Vestibuloplasty is a surgical procedure aimed at deepening the vestibule of the oral cavity, which is the space between the gums and the inner lining of the lips and cheeks. This procedure is particularly important in prosthodontics and oral surgery, as it can enhance the retention and stability of dentures by increasing the available denture-bearing area.

Types of Vestibuloplasty

  1. Vestibuloplasty (Sulcoplasty or Sulcus Deepening Procedure):

    • This procedure involves deepening the vestibule without the addition of bone. It is primarily focused on modifying the soft tissue to create a more favorable environment for denture placement.
    • Indications:
      • Patients with shallow vestibules that may compromise denture retention.
      • Patients requiring improved aesthetics and function of their prostheses.
    • Technique:
      • The procedure typically involves the excision of the mucosa and submucosal tissue to create a deeper vestibule.
      • The soft tissue is then repositioned to allow for a deeper sulcus, enhancing the area available for denture support.
  2. Labial Vestibular Procedure (Transpositional Flap Vestibuloplasty or Lip Switch Procedure):

    • This specific type of vestibuloplasty involves the transposition of soft tissue from the inner aspect of the lip to a more favorable position on the alveolar bone.
    • Indications:
      • Patients with inadequate vestibular depth who require additional soft tissue coverage for denture support.
      • Cases where the labial vestibule is shallow, affecting the retention of dentures.
    • Technique:
      • A flap is created from the inner lip, which is then mobilized and repositioned to cover the alveolar ridge.
      • This procedure increases the denture-bearing area by utilizing the soft tissue from the lip, thereby enhancing the retention and stability of the denture.
      • The flap is sutured into place, and the healing process allows for the integration of the new tissue position.

Benefits of Vestibuloplasty

  • Increased Denture Retention: By deepening the vestibule and increasing the denture-bearing area, patients often experience improved retention and stability of their dentures.
  • Enhanced Aesthetics: The procedure can improve the overall appearance of the oral cavity, contributing to better facial aesthetics.
  • Improved Function: Patients may find it easier to eat and speak with well-retained dentures, leading to improved quality of life.

Considerations and Postoperative Care

  • Healing Time: Patients should be informed about the expected healing time and the importance of following postoperative care instructions to ensure proper healing.
  • Follow-Up: Regular follow-up appointments may be necessary to monitor healing and assess the need for any adjustments to the dentures.
  • Potential Complications: As with any surgical procedure, there are risks involved, including infection, bleeding, and inadequate healing. Proper surgical technique and postoperative care can help mitigate these risks.

Le Fort I Fracture

  • A horizontal fracture that separates the maxilla from the nasal and zygomatic bones. It is also known as a "floating maxilla."

Signs and Symptoms:

  1. Bilateral Periorbital Edema and Ecchymosis: Swelling and bruising around the eyes (Raccoon eyes).
  2. Disturbed Occlusion: Malocclusion due to displacement of the maxilla.
  3. Mobility of the Maxilla: The maxilla may move independently of the rest of the facial skeleton.
  4. Nasal Bleeding: Possible epistaxis due to injury to the nasal mucosa.
  5. CSF Rhinorrhea: If there is a breach in the dura mater, cerebrospinal fluid may leak from the nose.

Le Fort II Fracture

  • A pyramidal fracture that involves the maxilla, nasal bones, and the zygomatic bones. It is characterized by a fracture line that extends from the nasal bridge to the maxilla and zygomatic arch.

Signs and Symptoms:

  1. Bilateral Periorbital Edema and Ecchymosis: Swelling and bruising around the eyes (Raccoon eyes).
  2. Diplopia: Double vision due to involvement of the orbital floor and potential muscle entrapment.
  3. Enophthalmos: Posterior displacement of the eyeball within the orbit.
  4. Restriction of Globe Movements: Limited eye movement due to muscle entrapment.
  5. Disturbed Occlusion: Malocclusion due to displacement of the maxilla.
  6. Nasal Bleeding: Possible epistaxis.
  7. CSF Rhinorrhea: If the dura is torn, cerebrospinal fluid may leak from the nose.

Le Fort III Fracture

  • A craniofacial disjunction fracture that involves the maxilla, zygomatic bones, and the orbits. It is characterized by a fracture line that separates the entire midface from the skull base.

Signs and Symptoms:

  1. Bilateral Periorbital Edema and Ecchymosis: Swelling and bruising around the eyes (Raccoon eyes).
  2. Orbital Dystopia: Abnormal positioning of the orbits, often with an antimongoloid slant.
  3. Diplopia: Double vision due to muscle entrapment or damage.
  4. Enophthalmos: Posterior displacement of the eyeball.
  5. Restriction of Globe Movements: Limited eye movement due to muscle entrapment.
  6. Disturbed Occlusion: Significant malocclusion due to extensive displacement of facial structures.
  7. CSF Rhinorrhea: If there is a breach in the dura mater, cerebrospinal fluid may leak from the nose or ears (CSF otorrhea).
  8. Bleeding Over Mastoid Process (Battle’s Sign): Bruising behind the ear may indicate a skull base fracture.

Microvascular Trigeminal Decompression (The Jannetta Procedure)

Microvascular decompression (MVD), commonly known as the Jannetta procedure, is a surgical intervention designed to relieve the symptoms of classic trigeminal neuralgia by addressing the underlying vascular compression of the trigeminal nerve. This procedure is particularly effective for patients who have not responded to medical management or who experience significant side effects from medications.

Overview of the Procedure

  1. Indication:

    • MVD is indicated for patients with classic trigeminal neuralgia, characterized by recurrent episodes of severe facial pain, often triggered by light touch or specific activities.
  2. Anesthesia:

    • The procedure is performed under general anesthesia to ensure the patient is completely unconscious and pain-free during the surgery.
  3. Surgical Approach:

    • The surgery is conducted using an intraoperative microscope for enhanced visualization of the delicate structures involved.
    • The arachnoid membrane surrounding the trigeminal nerve is carefully opened to access the nerve.
  4. Exploration:

    • The trigeminal nerve is explored from its entry point at the brainstem to the entrance of Meckel’s cave, where the trigeminal ganglion (Gasserian ganglion) is located.
  5. Microdissection:

    • Under microscopic and endoscopic visualization, the surgeon performs microdissection to identify and mobilize any arteries or veins that are compressing the trigeminal nerve.
    • The most common offending vessel is a branch of the superior cerebellar artery, but venous compression or a combination of arterial and venous compression may also be present.
  6. Decompression:

    • Once the offending vessels are identified, they are decompressed. This may involve:
      • Cauterization and division of veins that are compressing the nerve.
      • Placement of Teflon sponges between the dissected blood vessels and the trigeminal nerve to prevent further vascular compression.

Outcomes and Efficacy

  • Immediate Pain Relief:

    • Most patients experience immediate relief from facial pain following the decompression of the offending vessels.
    • Reports indicate rates of immediate pain relief as high as 90% to 98% after the procedure.
  • Long-Term Relief:

    • Many patients enjoy long-term relief from trigeminal neuralgia symptoms, although some may experience recurrence of pain over time.
  • Complications:

    • As with any surgical procedure, there are potential risks and complications, including infection, cerebrospinal fluid leaks, and neurological deficits. However, MVD is generally considered safe and effective.

Hemostatic Agents

Hemostatic agents are critical in surgical procedures to control bleeding and promote wound healing. Various materials are used, each with unique properties and mechanisms of action. Below is a detailed overview of some commonly used hemostatic agents, including Gelfoam, Oxycel, Surgical (Oxycellulose), and Fibrin Glue.

1. Gelfoam

  • Composition: Gelfoam is made from gelatin and has a sponge-like structure.

  • Mechanism of Action:

    • Gelfoam does not have intrinsic hemostatic properties; its hemostatic effect is primarily due to its large surface area, which comes into contact with blood.
    • When Gelfoam absorbs blood, it swells and exerts pressure on the bleeding site, providing a scaffold for the formation of a fibrin network.
  • Application:

    • Gelfoam should be moistened in saline or thrombin solution before application to ensure optimal performance. It is essential to remove all air from the interstices to maximize its effectiveness.
  • Absorption: Gelfoam is absorbed by the body through phagocytosis, typically within a few weeks.

2. Oxycel

  • Composition: Oxycel is made from oxidized cellulose.

  • Mechanism of Action:

    • Upon application, Oxycel releases cellulosic acid, which has a strong affinity for hemoglobin, leading to the formation of an artificial clot.
    • The acid produced during the wetting process can inactivate thrombin and other hemostatic agents, which is why Oxycel should be applied dry.
  • Limitations:

    • The acid produced can inhibit epithelialization, making Oxycel unsuitable for use over epithelial surfaces.

3. Surgical (Oxycellulose)

  • Composition: Surgical is a glucose polymer-based sterile knitted fabric created through the controlled oxidation of regenerated cellulose.

  • Mechanism of Action:

    • The local hemostatic mechanism relies on the binding of hemoglobin to oxycellulose, allowing the dressing to expand into a gelatinous mass. This mass acts as a scaffold for clot formation and stabilization.
  • Application:

    • Surgical can be applied dry or soaked in thrombin solution, providing flexibility in its use.
  • Absorption: It is removed by liquefaction and phagocytosis over a period of one week to one month. Unlike Oxycel, Surgical does not inhibit epithelialization and can be used over epithelial surfaces.

4. Fibrin Glue

  • Composition: Fibrin glue is a biological adhesive that contains thrombin, fibrinogen, factor XIII, and aprotinin.

  • Mechanism of Action:

    • Thrombin converts fibrinogen into an unstable fibrin clot, while factor XIII stabilizes the clot. Aprotinin prevents the degradation of the clot.
    • During wound healing, fibroblasts migrate through the fibrin meshwork, forming a more permanent framework composed of collagen fibers.
  • Applications:

    • Fibrin glue is used in various surgical procedures to promote hemostasis and facilitate tissue adhesion. It is particularly useful in areas where traditional sutures may be challenging to apply.

Rigid Fixation

Rigid fixation is a surgical technique used to stabilize fractured bones.

Types of Rigid Fixation

Rigid fixation can be achieved using various types of plates and devices, including:

  1. Simple Non-Compression Bone Plates:

    • These plates provide stability without applying compressive forces across the fracture site.
  2. Mini Bone Plates:

    • Smaller plates designed for use in areas where space is limited, providing adequate stabilization for smaller fractures.
  3. Compression Plates:

    • These plates apply compressive forces across the fracture site, promoting bone healing by encouraging contact between the fracture fragments.
  4. Reconstruction Plates:

    • Used for complex fractures or reconstructions, these plates can be contoured to fit the specific anatomy of the fractured bone.

Transosseous Wiring (Intraosseous Wiring)

Transosseous wiring is a traditional and effective method for the fixation of jaw bone fractures. It involves the following steps:

  1. Technique:

    • Holes are drilled in the bony fragments on either side of the fracture line.
    • A length of 26-gauge stainless steel wire is passed through the holes and across the fracture.
  2. Reduction:

    • The fracture must be reduced independently, ensuring that the teeth are in occlusion before securing the wire.
  3. Twisting the Wire:

    • After achieving proper alignment, the free ends of the wire are twisted to secure the fracture.
    • The twisted ends are cut short and tucked into the nearest drill hole to prevent irritation to surrounding tissues.
  4. Variations:

    • The single strand wire fixation in a horizontal manner is the simplest form of intraosseous wiring, but it can be modified in various ways depending on the specific needs of the fracture and the patient.

Other fixation techniques

Open reduction and internal fixation (ORIF):
Surgical exposure of the fracture site, followed by reduction and fixation with plates, screws, or nails

Closed reduction and immobilization (CRII):
Manipulation of the bone fragments into alignment without surgical exposure, followed by cast or splint immobilization

Intramedullary nailing:
Insertion of a metal rod (nail) into the medullary canal of the bone to stabilize long bone fractures

External fixation:
A device with pins inserted through the bone fragments and connected to an external frame to provide stability
 
Tension band wiring:
A technique using wires to apply tension across a fracture site, particularly useful for avulsion fractures

 

 

--------------------------------

Odontogenic Keratocyst (OKC)

The odontogenic keratocyst (OKC) is a unique and aggressive cystic lesion of the jaw with distinct histological features and a high recurrence rate. Below is a comprehensive overview of its characteristics, treatment options, and prognosis.

Characteristics of Odontogenic Keratocyst

  1. Definition and Origin:

    • The term "odontogenic keratocyst" was first introduced by Philipsen in 1956. It is believed to originate from remnants of the dental lamina or basal cells of the oral epithelium.
  2. Biological Behavior:

    • OKCs exhibit aggressive behavior and have a recurrence rate of 13% to 60%. They are considered to have a neoplastic nature rather than a purely developmental origin.
  3. Histological Features:

    • The cyst lining is typically 6 to 10 cells thick, with a palisaded basal cell layer and a surface of corrugated parakeratin.
    • The epithelium may produce orthokeratin (10%), parakeratin (83%), or both (7%).
    • No rete ridges are present, and mitotic activity is frequent, contributing to the cyst's growth pattern.
  4. Types:

    • Orthokeratinized OKC: Less aggressive, lower recurrence rate, often associated with dentigerous cysts.
    • Parakeratinized OKC: More aggressive with a higher recurrence rate.
  5. Clinical Features:

    • Age: Peak incidence occurs in individuals aged 20 to 30 years.
    • Gender: Predilection for males (approximately 1:5 male to female ratio).
    • Location: More commonly found in the mandible, particularly in the ramus and third molar area. In the maxilla, the third molar area is also a common site.
    • Symptoms: Patients may be asymptomatic, but symptoms can include pain, soft-tissue swelling, drainage, and paresthesia of the lip or teeth.
  6. Radiographic Features:

    • Typically appears as a unilocular lesion with a well-defined peripheral rim, although multilocular varieties (20%) can occur.
    • Scalloping of the borders is often present, and it may be associated with the crown of a retained tooth (40%).

Treatment Options for Odontogenic Keratocyst

  1. Surgical Excision:

    • Enucleation: Complete removal of the cyst along with the surrounding tissue.
    • Curettage: Scraping of the cyst lining after enucleation to remove any residual cystic tissue.
  2. Chemical Cauterization:

    • Carnoy’s Solution: Application of Carnoy’s solution (6 ml absolute alcohol, 3 ml chloroform, and 1 ml acetic acid) after enucleation and curettage can help reduce recurrence rates. It penetrates the bone and can assist in freeing the cyst from the bone wall.
  3. Marsupialization:

    • This technique involves creating a window in the cyst to allow for drainage and reduction in size, which can be beneficial in larger cysts or in cases where complete excision is not feasible.
  4. Primary Closure:

    • After enucleation and curettage, the site may be closed primarily or packed open to allow for healing.
  5. Follow-Up:

    • Regular follow-up is essential due to the high recurrence rate. Patients should be monitored for signs of recurrence, especially in the first few years post-treatment.

Prognosis

  • The prognosis for OKC is variable, with a significant recurrence rate attributed to the aggressive nature of the lesion and the potential for residual cystic tissue.
  • Recurrence is not necessarily related to the size of the cyst or the presence of satellite cysts but is influenced by the nature of the lesion itself and the presence of dental lamina remnants.
  • Multilocular lesions tend to have a higher recurrence rate compared to unilocular ones.
  • Surgical technique does not significantly influence the likelihood of relapse.

Associated Conditions

  • Multiple OKCs can be seen in syndromes such as:
    • Nevoid Basal Cell Carcinoma Syndrome (Gorlin-Goltz Syndrome)
    • Marfan Syndrome
    • Ehlers-Danlos Syndrome
    • Noonan Syndrome

Explore by Exams